Return to study ST002523 main page
MB Sample ID: SA254508
| Local Sample ID: | MT245 |
| Subject ID: | SU002623 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Age Or Age Range: | 68 (63, 73) |
| Weight Or Weight Range: | 77 (62, 87) |
| Height Or Height Range: | 170 (160, 176) |
| Gender: | Male and female |
| Human Ethnicity: | White |
| Human Medications: | anti-PD-1 immune checkpoint inhibitors (nivolumab or pembrolizumab) |
| Human Inclusion Criteria: | consecutive advanced cancer patients |
Select appropriate tab below to view additional metadata details:
Factors:
| Local Sample ID | MB Sample ID | Factor Level ID | Level Value | Factor Name |
|---|---|---|---|---|
| MT245 | SA254508 | FL032605 | Low | Candida |
| MT245 | SA254508 | FL032605 | Male | Gender |
| MT245 | SA254508 | FL032605 | Nivolumab | Immunotherapy |
